companydata.dkKurm Pharma ApS: Financial statements 2018
CVR: 39181274
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 494,249 and a net result of DKK 347,758. Equity amounted to DKK 397,758. The solvency ratio was 12.7%.
- Gross Profit
- 494,249 kr.
- Profit/Loss
- 347,758 kr.
- Equity
- 397,758 kr.
- Total Assets
- 3,127,068 kr.
Keep an eye on Kurm Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of January 11, 2018, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Kurm Pharma ApS.
As of January 11, 2018, KVIST & JENSEN, GRENAA STATSAUTORISEREDE REVISORER A/S has stepped down as auditor of Kurm Pharma ApS.
As of January 5, 2018, Jacob Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Jesper Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Johannes Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Peter Vammen has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Steen Nordstrøm has joined the board of directors of Kurm Pharma ApS.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity amounted to DKK 1,813,033.